|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2011-4-7
|
|
pubmed:abstractText |
There is a high prevalence of low testosterone and dyslipidaemia in men with type 2 diabetes. The androgen receptor CAG repeat polymorphism (AR CAG) affects receptor transcriptional activity (the shorter repeats the more sensitive AR) and is associated with androgenic parameters and obesity. This study describes the relationships between testosterone, AR CAG and serum lipids in men with type 2 diabetes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1365-2265
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
© 2011 Blackwell Publishing Ltd.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
74
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
624-30
|
|
pubmed:meshHeading |
pubmed-meshheading:21470285-Aged,
pubmed-meshheading:21470285-Cholesterol, HDL,
pubmed-meshheading:21470285-Cross-Sectional Studies,
pubmed-meshheading:21470285-Diabetes Mellitus, Type 2,
pubmed-meshheading:21470285-Dyslipidemias,
pubmed-meshheading:21470285-Estradiol,
pubmed-meshheading:21470285-Humans,
pubmed-meshheading:21470285-Male,
pubmed-meshheading:21470285-Middle Aged,
pubmed-meshheading:21470285-Polymorphism, Genetic,
pubmed-meshheading:21470285-Receptors, Androgen,
pubmed-meshheading:21470285-Testosterone,
pubmed-meshheading:21470285-Trinucleotide Repeats
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Dyslipidaemia is associated with testosterone, oestradiol and androgen receptor CAG repeat polymorphism in men with type 2 diabetes.
|
|
pubmed:affiliation |
Centre for Diabetes and Endocrinology, Barnsley Hospital NHS Foundation Trust, Barnsley, South Yorkshire, UK.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
